Cite
Aaboe Jørgensen M, Ugel S, Linder Hübbe M, et al. Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. Cancer Immunol Res. 2021;9(11):1316-1326doi: 10.1158/2326-6066.CIR-21-0280.
Aaboe Jørgensen, M., Ugel, S., Linder Hübbe, M., Carretta, M., Perez-Penco, M., Weis-Banke, S. E., Martinenaite, E., Kopp, K., Chapellier, M., Adamo, A., De Sanctis, F., Frusteri, C., Iezzi, M., Zocca, M. B., Hargbøll Madsen, D., Wakatsuki Pedersen, A., Bronte, V., & Andersen, M. H. (2021). Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. Cancer immunology research, 9(11), 1316-1326. https://doi.org/10.1158/2326-6066.CIR-21-0280
Aaboe Jørgensen, Mia, et al. "Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade." Cancer immunology research vol. 9,11 (2021): 1316-1326. doi: https://doi.org/10.1158/2326-6066.CIR-21-0280
Aaboe Jørgensen M, Ugel S, Linder Hübbe M, Carretta M, Perez-Penco M, Weis-Banke SE, Martinenaite E, Kopp K, Chapellier M, Adamo A, De Sanctis F, Frusteri C, Iezzi M, Zocca MB, Hargbøll Madsen D, Wakatsuki Pedersen A, Bronte V, Andersen MH. Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. Cancer Immunol Res. 2021 Nov;9(11):1316-1326. doi: 10.1158/2326-6066.CIR-21-0280. Epub 2021 Sep 13. PMID: 34518197.
Copy
Download .nbib